Sept 24. Ulf Grawunder, CEO of T-CURX, invited to present T-CURX at the 10th CAR-TCR-T congress in Boston

Ulf Grawunder, CEO and co-founder of T-CURX, has been invited as speaker at the 10th international CAR-T-TCR-T congress in Boston, Massachussetts

The CAR-T-TCR-T congress organized for the 10th year by Hans-Wade and taking place from Sept 23-26 in Boston, Massachussetts, is one of the leading events in the cell-therapy space in which stakeholders of the CAR-T and TCR-T cell therapy industry meet. T-CURX CEO and co-founder, Ulf Grawunder, has been invited to present about where Large-Scale Manufacturing is heading to nowadays, with recent advances in achieving CAR-T generation by administering CAR-T vectors in patients systemically and in vivo. Ulf's presentation is entitled «Large-Scale CAR-T manufacturing for patients globally – Quo vadis?». Ulf’s presentation takes place in the «Large-Scale Manufacturing stream» at the venue site in the Marriott at Copley Place (110 Huntington Ave., Boston, MA 02116) on Sept 24, from 11:00-11:25 a.m. ET.